|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
OB: Mixed Reviews On Drug To Prevent Preterm BirthFrom: art fougner, md (evsono@pipeline.com)Tue Aug 29 12:37:44 2006
A drug to help women carry their babies to term that is awaiting federal approval doesn't appear to delay the earliest preterm births most often linked to death and serious health problems, according to federal documents released yesterday. The results of a single clinical trial were not "statistically persuasive" in suggesting that the injectable drug, Gestiva, reduced births before either 32 or 35 weeks' gestation, Food and Drug Administration documents show. However, the drug does appear to reduce births before the 37th week, considered the cutoff point for a newborn to be considered premature, study results suggest. Adeza Biomedical Corp. said in FDA filings that weekly injections of Gestiva lead to a "substantial reduction" in preterm births among women most at risk. " http://www.newsday.com/news/health/ny-hspree294869380aug29,0,5906224.story " Art
-- art fougner, md "May The Wings of Liberty Never Lose a Feather." - Jack Burton
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Fri May 2 04:45:41 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.